MAPT and Alzheimer disease: Similarly, 3xTg AD mice that received MitoQ in drinking water for 5 months exhibited a reduction in astrogliosis, synapse loss, Aβ aggregation, microglial activation, and tau hyperphosphorylation, which was associated with improved memory ability and delayed death [495,496,531].